相关实验视频
Updated: Jan 12, 2026

06:27
Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
8.5K
由于不同的治疗方案和设备,极度早产新生儿的光疗暴露变化:横截面研究
Daniele De Luca1,2, Costanza Neri3, Vanessa Monin3
1Physiopathology and Therapeutic Innovation INSERM-U999, Paris Saclay University, Paris, France. dm.deluca@icloud.com.
概括
由于不同的治疗方案和设备,早产婴儿的光疗暴露有很大差异. 这影响了治疗持续时间和光谱功率,突出了对标准化方法的需求.
科学领域:
- 新生儿护理 新生儿护理
- 儿科照明疗法儿童照明疗法
背景情况:
- 极度早产的婴儿通常需要照相治疗,以治疗诸如黄等疾病.
- 光疗方案和设备的变化可能会影响治疗疗效和婴儿的结果.
研究的目的:
- 为了研究极度早产婴儿的光疗暴露的变化.
- 根据治疗方案和设备,分析光疗持续时间和光谱功率的差异.
主要方法:
- 对42名接受发光二极管 (LED) 光疗的极早产婴儿进行横截面观察研究.
- 根据各种专家指南计算光疗持续时间.
- 测量了LED设备的辐射和估计的光谱功率.
主要成果:
- 在不同方案中,光疗持续时间 (0-72小时) 有显著差异 (p < 0.001).
- 在LED设备之间,光谱功率 (8.6-17.8 mW/nm) 的实质性变化 (p < 0.001).
- 对于持续时间 (66.6%) 和光谱功率 (18.1%) 均观察到高的中位变化系数.
结论:
- 在早产婴儿中,照相疗法的暴露是高度可变的.
- 治疗方案和LED设备的差异导致累计治疗持续时间和光谱功率的显著变化.
- 光疗方案和设备的标准化可能是合理的,以确保一致的婴儿护理.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
201
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
201
Pharmacokinetics in Pediatric Patients: Drug Distribution
249
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
Pharmacokinetics in Pediatric Patients: Drug Metabolism
185
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
185
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
239
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
239

